Public coverage rules with clinician-led review
One public set of coverage rules; payment decisions are made by a public agency with clinicians, and appeals go to an independent board.
One public rulebook with independent appeals.
To review: Moves 'no' to program-wide decisions; see the rationing subpaths.
Review ledgerHow this path connects
Addresses
Claim denialsThis path
Public coverage rules with clinician-led review
Requires:
Single public payer for everyoneTens of millions of people have no coverageChosenConcrete changes if chosen
What would actually have to change in law, agencies, payment rules, or systems.
- Publish one national coverage rulebook
- Create an independent appeals board with clinician reviewers
Effects
Each effect has its own page: the evidence, the case that it is or isn't a real cost, and whom it affects.
What it fixes
- Claim denials
Public coverage rules administered with clinicians and independent appeals replace many claim-level denials with consistent rules for every patient and provider.
What it creates or worsens
- Limits choice or applies one rule to every setting
An error in the shared rulebook affects everyone.
- Central coverage decisions can feel like rationing
Public coverage decisions move refusals from individual claims to program-wide rules.
3 paths soften this
Independent, transparent coverage body with appealsCentral coverage decisions can feel like rationingChosenCover everything clinically effective, without cost thresholdsCentral coverage decisions can feel like rationingRejectedClinician-led exceptions with fast reviewCentral coverage decisions can feel like rationingChosen
Who's affected
Who gains
- People with ongoing or specialist care needs
- Claim denials: Care is delayed or denied, and appeals take time.
- Doctors, nurses, and other clinicians
- Claim denials: Providers absorb unpaid claims and appeal work.
- Taxpayers and public budgets
- Central coverage decisions can feel like rationing: Declining low-value care holds down public spending.
Who loses
- Health insurers, brokers, and their shareholders
- Claim denials: Denials lower insurers' medical spending.
- Health administration and software vendors
- Limits choice or applies one rule to every setting: An error in the shared rulebook affects everyone.
- People with ongoing or specialist care needs
- Central coverage decisions can feel like rationing: People needing a declined or delayed treatment have no other insurer to turn to.
- Drug and device makers
- Central coverage decisions can feel like rationing: A declined product loses the whole national market.
Other ways to soften the losses
- Transition program
Where it has been tried
- Canada, Taiwan: Few claim-level denials; coverage limits are set at the program level instead.
- Taiwan: In a 2017 Taiwan claims-review experiment, decisions judged too harsh fell from 11.08% to 2.59% of assessed cases when physician reviewers' identities were disclosed.Sources: Scientific Reports (2022)